Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study
出版年份 2019 全文链接
标题
Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study
作者
关键词
-
出版物
BMJ-British Medical Journal
Volume -, Issue -, Pages l67
出版商
BMJ
发表日期
2019-01-25
DOI
10.1136/bmj.l67
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The C-Word: Scientific Euphemisms Do Not Improve Causal Inference From Observational Data
- (2018) Miguel A. Hernán AMERICAN JOURNAL OF PUBLIC HEALTH
- Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards
- (2017) Hakim-Moulay Dehbi et al. BMJ-British Medical Journal
- Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards
- (2017) Hakim-Moulay Dehbi et al. BMJ-British Medical Journal
- Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.
- (2016) Miguel A. Hernán et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Comparative efficacy of tocilizumab, abatacept and rituximab after non-TNF inhibitor failure: results from a multicentre study
- (2016) Tristan Pascart et al. International Journal of Rheumatic Diseases
- Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis
- (2016) J. E. Gottenberg et al. Arthritis & Rheumatology
- Rituximab done: what’s next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis
- (2015) Ulrich A. Walker et al. RHEUMATOLOGY
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
- (2015) Peter C. Austin et al. STATISTICS IN MEDICINE
- Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy
- (2014) Sudipto Das et al. ANNALS OF THE RHEUMATIC DISEASES
- Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial
- (2013) Michael Schiff et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
- (2013) Cem Gabay et al. LANCET
- Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry
- (2012) J E Gottenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis
- (2012) Monika Schoels et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry
- (2011) H. C. Leffers et al. ANNALS OF THE RHEUMATIC DISEASES
- The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt
- (2011) Patrick Royston et al. STATISTICS IN MEDICINE
- Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis
- (2010) C. Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
- (2010) J.-E. Gottenberg et al. ARTHRITIS AND RHEUMATISM
- Rheumatoid arthritis
- (2010) David L Scott et al. LANCET
- Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries
- (2010) X. Mariette et al. RHEUMATOLOGY
- Indirect Comparison of Tocilizumab and Other Biologic Agents in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs
- (2010) Gert J.D. Bergman et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry
- (2009) Merete Lund Hetland et al. ARTHRITIS AND RHEUMATISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started